| Literature DB >> 26104998 |
Sietse M Aukema1,2,3, Laura Theil1, Marius Rohde4, Benedikt Bauer5, Jutta Bradtke6, Birgit Burkhardt7, Bettina R Bonn7, Alexander Claviez8, Stefan Gattenlöhner6, Olga Makarova7, Inga Nagel1, Ilske Oschlies9, Christiane Pott10, Monika Szczepanowski9, Arne Traulsen6, Philip M Kluin2, Wolfram Klapper9, Reiner Siebert1, Eva M Murga Penas1.
Abstract
Typical Burkitt lymphoma is characterized by an IG-MYC translocation and overall low genomic complexity. Clinically, Burkitt lymphoma has a favourable prognosis with very few relapses. However, the few patients experiencing disease progression and/or relapse have a dismal outcome. Here we report cytogenetic findings of seven cases of Burkitt lymphoma in which sequential karyotyping was performed at time of diagnosis and/or disease progression/relapse(s). After case selection, karyotype re-review and additional molecular analyses were performed in six paediatric cases, treated in Berlin-Frankfurt-Münster-Non-Hodgkin lymphoma study group trials, and one additional adult patient. Moreover, we analysed 18 cases of Burkitt lymphoma from the Mitelman database in which sequential karyotyping was performed. Our findings show secondary karyotypes to have a significant increase in load of cytogenetic aberrations with a mean number of 2, 5 and 8 aberrations for primary, secondary and third investigations. Importantly, this increase in karyotype complexity seemed to result from recurrent secondary chromosomal changes involving mainly trisomy 21, gains of 1q and 7q, losses of 6q, 11q, 13q, and 17p. In addition, our findings indicate a linear clonal evolution to be the predominant manner of cytogenetic evolution. Our data may provide a biological framework for the dismal outcome of progressive and relapsing Burkitt lymphoma.Entities:
Keywords: Burkitt lymphoma; MYC; clonal evolution; progression; relapse
Mesh:
Substances:
Year: 2015 PMID: 26104998 DOI: 10.1111/bjh.13501
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998